Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William P Melega

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Addictive Diseases|February 8, 2002
Patterns of methamphetamine abuse and their consequencesArthur K Cho, William P Melega
Synapse (New York, N.Y.)|February 19, 2013
Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administrationGoran Laćan, Martin Hadamitzky, Ronald Kuczenski, et al.
Synapse (New York, N.Y.)|January 19, 2007
Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modelingWilliam P Melega, Arthur K Cho, Dennis Harvey, et al.
Neuroreport|October 9, 2007
Methamphetamine increases basal ganglia iron to levels observed in agingWilliam P Melega, Goran Laćan, Dennis C Harvey, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 3, 2009
Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h bingeRonald Kuczenski, David S Segal, William P Melega, et al.
Psychopharmacology|June 17, 2005
Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterizationDavid S Segal, Ronald Kuczenski, Meghan L O'Neil, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2003
Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine bingeDavid S Segal, Ronald Kuczenski, Meghan L O'Neil, et al.
Plos One|February 2, 2012
Hypothalamic deep brain stimulation reduces weight gain in an obesity-animal modelWilliam P Melega, Goran Lacan, Alessandra A Gorgulho, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Regulation of Kaposi's sarcoma-associated herpesvirus reactivation by dopamine receptor-mediated signaling pathwaysShaoying Lee, Hongyu Deng, Fuqu Yu, et al.
Synapse (New York, N.Y.)|August 10, 2006
Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine bingeMeghan L O'Neil, Ronald Kuczenski, David S Segal, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Addictive Diseases|February 8, 2002
Patterns of methamphetamine abuse and their consequencesArthur K Cho, William P Melega
Synapse (New York, N.Y.)|February 19, 2013
Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administrationGoran Laćan, Martin Hadamitzky, Ronald Kuczenski, et al.
Synapse (New York, N.Y.)|January 19, 2007
Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modelingWilliam P Melega, Arthur K Cho, Dennis Harvey, et al.
Neuroreport|October 9, 2007
Methamphetamine increases basal ganglia iron to levels observed in agingWilliam P Melega, Goran Laćan, Dennis C Harvey, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 3, 2009
Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h bingeRonald Kuczenski, David S Segal, William P Melega, et al.
Psychopharmacology|June 17, 2005
Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterizationDavid S Segal, Ronald Kuczenski, Meghan L O'Neil, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2003
Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine bingeDavid S Segal, Ronald Kuczenski, Meghan L O'Neil, et al.
Plos One|February 2, 2012
Hypothalamic deep brain stimulation reduces weight gain in an obesity-animal modelWilliam P Melega, Goran Lacan, Alessandra A Gorgulho, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Regulation of Kaposi's sarcoma-associated herpesvirus reactivation by dopamine receptor-mediated signaling pathwaysShaoying Lee, Hongyu Deng, Fuqu Yu, et al.
Synapse (New York, N.Y.)|August 10, 2006
Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine bingeMeghan L O'Neil, Ronald Kuczenski, David S Segal, et al.
Pageof 3